Literature DB >> 11375774

PTHrP: novel roles in skeletal biology.

A C Karaplis1.   

Abstract

Parathyroid hormone-related peptide (PTHrP) was discovered as the main mediator of humoral hypercalcemia associated with malignancy but is now known to be expressed by a variety of normal fetal and adult tissues. The amino-terminal region of PTHrP reveals limited but significant homology with parathyroid hormone (PTH), resulting in the interaction of either peptide with a common seven-transmembrane spanning G-protein linked receptor termed the PTH/PTHrP receptor. Targeted inactivation of PTHrP and its receptor in mice has established a critical role for this signaling pathway in chondrocyte biology and endochondral bone formation. Animals homozygous for the targeted alleles demonstrate marked skeletal deformities arising from impaired chondrocyte proliferation, premature differentiation and accelerated apoptosis. The complex processes resulting in normal endochondral bone development involve additional factors such as the hedgehog signaling pathway with which PTHrP interacts. PTHrP, like PTH, also binds to receptors on cells of the osteoblast lineage resulting in enhanced bone formation and also, indirectly, augmented osteoclastic bone resorption. The marked premature osteoporosis observed in mice heterozygous for the disrupted Pthrp allele also points to a crucial role for the protein in the maintenance of the adult skeleton. Further studies into this process are likely to reveal new facets of the pathogenesis underlying a variety of metabolic bone diseases and potentially point to new directions for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375774     DOI: 10.2174/1381612013397753

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

Review 1.  Evolution and Cell Physiology. 1. Cell signaling is all of biology.

Authors:  John S Torday
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-24       Impact factor: 4.249

2.  Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice.

Authors:  Mahita Kadmiel; Kimberly Fritz-Six; Suruchi Pacharne; Gareth O Richards; Manyu Li; Tim M Skerry; Kathleen M Caron
Journal:  Mol Endocrinol       Date:  2011-05-12

3.  PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.

Authors:  Jiarong Li; Andrew C Karaplis; Dao C Huang; Peter M Siegel; Anne Camirand; Xian Fang Yang; William J Muller; Richard Kremer
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

4.  Observation of Solute Transport between Articular Cartilage and Subchondral Bone in Live Mice.

Authors:  Yang Huang; Cheng Chen; Fuyou Wang; Guangxin Chen; Shidi Cheng; Zhexiong Tang; Zheng Li; Xiaoyuan Gong; Liu Yang
Journal:  Cartilage       Date:  2020-08-25       Impact factor: 3.117

5.  PTHrP, PTHr, and FGFR3 are involved in the process of endochondral ossification in human osteophytes.

Authors:  Klaus Huch; Sandra Kleffner; Johannes Stöve; Wolfhart Puhl; Klaus-Peter Günther; Rolf Erwin Brenner
Journal:  Histochem Cell Biol       Date:  2003-04-12       Impact factor: 4.304

Review 6.  Mechanotransduction as an Adaptation to Gravity.

Authors:  Tanbir Najrana; Juan Sanchez-Esteban
Journal:  Front Pediatr       Date:  2016-12-26       Impact factor: 3.418

Review 7.  Regulation of Hedgehog signaling Offers A Novel Perspective for Bone Homeostasis Disorder Treatment.

Authors:  Wen-Ting Lv; Dong-Hua Du; Rui-Juan Gao; Chun-Wei Yu; Yan Jia; Zhi-Feng Jia; Chun-Jie Wang
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

8.  The association between environmental lead exposure and bone density in children.

Authors:  James R Campbell; Randy N Rosier; Leonore Novotny; J Edward Puzas
Journal:  Environ Health Perspect       Date:  2004-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.